insights_auto
Why is INO up 24,28%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,51 US$
arrow_upward
+24,28%(+0,29) 1D
1,51 US$
0,00% (0,00)
bedtimeAfter hours
Closed: 9 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,30 US$
High
1,60 US$
Low
1,26 US$
Mkt. cap
155,49 მლნ.
Avg. vol.
17,42 მლნ.
Volume
0,00
52-wk high
2,72 US$
52-wk low
0,57 US$
EPS
-1,17 US$
Beta
1,71
Shares outstanding
103,40 მლნ.
No. of employees
112
Open
1,30 US$
High
1,60 US$
Low
1,26 US$
Mkt. cap
155,49 მლნ.
Avg. vol.
17,42 მლნ.
Volume
0,00
52-wk high
2,72 US$
52-wk low
0,57 US$
EPS
-1,17 US$
Beta
1,71
Shares outstanding
103,40 მლნ.
No. of employees
112
News stories
From web sources and news partners
Investing.com Canada
·
18 საათის წინ
Form 8K Inovio Pharmaceuticals Inc For: 9 November By Investing.com
TradingView
·
19 საათის წინ
INO Q3'26 Earnings: EPS estimate is (0.20) USD
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc